Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractDetection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors    Next AbstractChemical sensors for breath gas analysis: the latest developments at the Breath Analysis Summit 2013 »

Nanomedicine (Lond)


Title:Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors
Author(s):Tisch U; Schlesinger I; Ionescu R; Nassar M; Axelrod N; Robertman D; Tessler Y; Azar F; Marmur A; Aharon-Peretz J; Haick H;
Address:"The Department of Chemical Engineering & Russell Berrie Nanotechnology Institute, Technion - Israel Institute of Technology, Haifa 32000, Israel"
Journal Title:Nanomedicine (Lond)
Year:2013
Volume:20121015
Issue:1
Page Number:43 - 56
DOI: 10.2217/nnm.12.105
ISSN/ISBN:1748-6963 (Electronic) 1743-5889 (Linking)
Abstract:"AIM: To study the feasibility of a novel method in nanomedicine that is based on breath testing for identifying Alzheimer's disease (AD) and Parkinson's disease (PD), as representative examples of neurodegenerative conditions. PATIENTS & METHODS: Alveolar breath was collected from 57 volunteers (AD patients, PD patients and healthy controls) and analyzed using combinations of nanomaterial-based sensors (organically functionalized carbon nanotubes and gold nanoparticles). Discriminant factor analysis was applied to detect statistically significant differences between study groups and classification success was estimated using cross-validation. The pattern identification was supported by chemical analysis of the breath samples using gas chromatography combined with mass spectrometry. RESULTS: The combinations of sensors could clearly distinguish AD from healthy states, PD from healthy states, and AD from PD states, with a classification accuracy of 85, 78 and 84%, respectively. Gas chromatography combined with mass spectrometry analysis showed statistically significant differences in the average abundance of several volatile organic compounds in the breath of AD, PD and healthy subjects, thus supporting the breath prints observed with the sensors. CONCLUSION: The breath prints that were identified with combinations of nanomaterial-based sensors have future potential as cost-effective, fast and reliable biomarkers for AD and PD"
Keywords:"Adult Aged Aged, 80 and over Alzheimer Disease/*diagnosis *Breath Tests Case-Control Studies Gas Chromatography-Mass Spectrometry Humans Middle Aged *Nanostructures Parkinson Disease/*diagnosis;"
Notes:"MedlineTisch, Ulrike Schlesinger, Ilana Ionescu, Radu Nassar, Maria Axelrod, Noa Robertman, Dorina Tessler, Yael Azar, Faris Marmur, Abraham Aharon-Peretz, Judith Haick, Hossam eng England 2012/10/17 Nanomedicine (Lond). 2013 Jan; 8(1):43-56. doi: 10.2217/nnm.12.105. Epub 2012 Oct 15"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-09-2024